
Centogene is expanding its corporate ERP, Microsoft Dynamics 365 — already deployed and operational at the parent company — to between 5 and 10 international subsidiaries. The functional scope covers Finance (General Ledger, Accounts Payable, Accounts Receivable) and basic Supply Chain Management (Procurement, Sales, Inventory Management), with a strong focus on intercompany processes.
A central element of this project is building a standardized and replicable implementation model that enables rapid and consistent rollouts to each new subsidiary, supported by local partners in each region. This is not just about implementing D365: it is about designing the way Centogene implements D365.
A professional with hands-on experience in D365 Finance & SCM implementations, combining strong configuration and parameterization skills with sufficient technical knowledge to deliver customizations and integrations. Someone who has participated in multi-entity or multi-country rollouts and is able to contribute to the design of a scalable implementation model.
Centogene is a global leader in genetic diagnostics and precision medicine, founded in 2006 and headquartered in Rostock, Germany. With presence in over 100 countries, approximately 450 employees across 5 continents, and one of the largest genetic databases in the world, Centogene transforms clinical, genetic, and biochemical data into medical solutions for patients. Recently backed by Charme Capital Partners, the company is undergoing a phase of transformation and global growth.

CENTOGENE is a leading company in the field of genetic diagnostics and precision medicine, dedicated to transforming clinical, genetic, and biochemical data into medical solutions for patients. Based in Rostock, Germany, the company operates globally.
Founded in 2006 with the mission of revolutionizing the diagnosis of rare diseases, CENTOGENE has since scaled its capabilities to diagnose more than 2,500 rare diseases in over 100 countries, building one of the largest genetic databases in the world (1,000,000 individuals) while developing cutting-edge technology for the interpretation of genetic data. With over 350 scientific publications, CENTOGENE is a key partner for physicians in rapid and accurate genetic diagnosis, and for pharmaceutical companies focused on developing treatments for orphan diseases.